SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015077
Filing Date
2020-08-10
Accepted
2020-08-10 15:55:34
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 900035
2 ex10-1.htm EX-10.1 9877
3 ex31-1.htm EX-31.1 19120
4 ex31-2.htm EX-31.2 19098
5 ex32.htm EX-32 12498
6 chart_01.jpg GRAPHIC 113120
  Complete submission text file 0001493152-20-015077.txt   4331910

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE abeo-20200630.xsd EX-101.SCH 27225
8 XBRL CALCULATION FILE abeo-20200630_cal.xml EX-101.CAL 46932
9 XBRL DEFINITION FILE abeo-20200630_def.xml EX-101.DEF 85375
10 XBRL LABEL FILE abeo-20200630_lab.xml EX-101.LAB 238077
11 XBRL PRESENTATION FILE abeo-20200630_pre.xml EX-101.PRE 188286
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 683758
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 201089192
SIC: 2834 Pharmaceutical Preparations